Indefinite Delivery Contract SPE2DR25D2911

Award Date 9/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp. The contract, valued at $999,999,999, has a period of performance running through December 2036 and provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract aims to establish Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN...
The federal contract IDV award SPE2DR25D3010 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC has an ultimate completion date of December 31, 2026 and serves as a prime vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, provides worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, the U.S. Coast Guard, and U.S. Naval Fleet. The contract covers a broad...
The federal contract IDV award SPE2DR25D6029 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp. The $999,999,999 contract, which runs through December 2036, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and...
The federal contract IDV award SPE2DU25D7050 is an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has an ultimate completion date of December 31, 2036 and provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
The federal contract IDV award SPE2DR25D7059 is a $999,999,999 Indefinite Delivery Contract issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp. This single-award contract runs through December 31, 2036 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including...
The federal contract IDV award SPE2DR25D3304 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, has a period of performance through December 31, 2026 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The federal contract IDV award SPE2DR25D2209 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp. The contract, valued at $999,999,999, aims to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The contract...
The federal contract IDV award SPE2DR25D1931 is an Indefinite Delivery Contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, has an ultimate completion date of December 31, 2036 and provides worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The contract aims to establish...
The federal contract IDV award to Amerisourcebergen Drug Corp, valued at $999,999,999, is an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract aims to establish Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The...

The federal contract IDV award SPE2DR25D2911 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $999,999,999 and a performance period through December 2036.

The contract aims to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) that will provide worldwide pharmaceutical support, including brand-name, generic, and specialty medications, as well as related medical supplies, to various Department of Defense (DoD) customers, the U.S. Coast Guard, and other government agencies. The IDC will enable efficient procurement of essential pharmaceutical and medical commodities to support normal operations, contingencies, and readiness for military healthcare programs globally. The procurement is being conducted as an unrestricted, fully competitive acquisition with a Lowest Price Technically Acceptable (LPTA) evaluation methodology. The solicitation is expected to be issued in March 2024 with an estimated total value of $30.3 billion for all regions and options.

Generated 6/6/25, 9:48 AM